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he mammalian nuclear lamina protein lamin B1 is
posttranslationally modified by farnesylation, endo-
proteolysis, and carboxymethylation at a carboxyl-
terminal CAAX motif. In this work, we demonstrate that the
CAAX endoprotease Rce1 is required for lamin B1 endo-
proteolysis, demonstrate an independent pool of proteolyzed
but nonmethylated lamin B1, as well as fully processed lamin
B1, in interphase nuclei, and show a role for methylation
T
 
in the organization of lamin B1 into domains of the nuclear
lamina. Deficiency in the endoproteolysis or methylation
of lamin B1 results in loss of integrity and deformity of the
nuclear lamina. These data show that the organization of the
nuclear envelope and lamina is dependent on a mechanism
involving the methylation of lamin B1, and they identify a
 
potential mechanism of laminopathy involving a B-type lamin.
 
Introduction
 
The nuclear lamina is a dense intermediate filament poly-
mer underlying the nuclear envelope of higher eukaryotes
(Goldman et al., 2002; Hutchison, 2002). It interacts closely
with both the inner membrane of the nuclear envelope and
the underlying chromatin, and these associations are thought
to be important in maintaining the stability of the interphase
nucleus. Interactions between peripheral heterochromatin
domains and the nuclear lamina may be important in the
control of gene expression and gene silencing (Labrador and
Corces, 2002).
In somatic cells, the nuclear lamina is focally concentrated
in regions of peripheral chromatin attachment (Paddy et al.,
 
1990; Belmont et al., 1993). The nonhomogeneous distribution
of the lamina at the nuclear periphery is likely to arise from a
 
combination of factors, including interactions with chromatin,
binding of inner nuclear membrane proteins, expression
patterns of the lamin proteins, and posttranslational modifi-
cations of the lamin proteins. The lamina contains both
A-type and B-type lamins, which are type V intermediate
filament proteins that form the building blocks of the poly-
mer (Stuurman et al., 1998). The B-type lamins, including
lamins B1 and B2, are ubiquitously expressed and are essential
developmental proteins in 
 
Drosophila melanogaster 
 
and
 
Caenorhabditis elegans
 
 models (Lenz-Bohme et al., 1997; Liu
et al., 2000). The A-type lamins, which include lamin A and
its truncated splice variant lamin C, are expressed in most,
 
but not all, terminally differentiated cells (Lehner et al., 1987).
All lamin proteins except lamin C terminate in a CAAX
motif (cysteine, aliphatic, aliphatic, any of several amino acids)
that triggers a series of sequential posttranslational modifica-
tions at the carboxyl terminus (Stuurman et al., 1998). First,
a farnesyl moiety is attached to the thiol group of the
cysteine (the “C” of the CAAX motif) by protein farnesyl-
transferase. Next, the terminal three amino acids (i.e., the
“AAX”) are removed by one of two endoproteases, discussed
later in this paragraph. Finally, the carboxylate anion of
the then carboxyl-terminal farnesylcysteine is methylated
by isoprenylcysteine carboxyl methyltransferase (Icmt).
Both endoproteolysis and carboxymethylation are dependent
on farnesylation of the cysteine residue and are membrane-
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associated processing events (Dai et al., 1998; Otto et al.,
1999). Farnesylation is important for the peripheral localiza-
tion and membrane association of the lamins. Endoproteolysis
and subsequent methylation increase the hydrophobicity of the
carboxyl terminus and may stabilize the membrane association.
CAAX endoproteases include Rce1 (Otto et al., 1999), which
processes farnesylated Ras proteins as well as other CAAX pro-
teins, and Zmpste24, which almost certainly is involved in the
processing of the carboxyl terminus of pre–lamin A (Bergo et
al., 2002b). In this paper, we demonstrate that the Rce1
CAAX endoprotease is required for lamin B1 endoproteolysis.
Deficiencies of the mammalian CAAX processing en-
zymes cause severe phenotypic changes in mouse models.
 
Rce1
 
 deficiency causes death late in embryonic development
despite apparently normal organogenesis (Kim et al., 1999).
A deficiency in 
 
Zmpste24 
 
causes defective processing of pre–
lamin A, spontaneous bone fractures, and muscle weakness
(Bergo et al., 2002b; Pendas et al., 2002). 
 
Icmt 
 
deficiency is
lethal at mid-gestation (Bergo et al., 2001), perhaps because
of agenesis of the liver (Lin et al., 2002). A deficiency in pro-
tein farnesyltransferase, caused by a knockout of the gene for
the 
 

 
-subunit of the enzyme, is lethal at embryonic day 6 to
7 (unpublished data). All of the enzymes involved in the
processing of CAAX proteins are potential antineoplastic
targets, and various farnesyltransferase inhibitors (FTIs)
have already been tested in human clinical trials (Bergo et
al., 2000, 2002a; Sebti and Hamilton, 2001). Interestingly,
defective Zmpste24-mediated processing of pre–lamin A re-
sults in a muscle weakness phenotype similar to that ob-
served in lamin A/C deficiency in mice (Sullivan et al.,
1999; Bergo et al., 2002b; Pendas et al., 2002). In humans,
specific mutations in lamins A and C cause Emery-Dreifuss
muscular dystrophy and an axonal neuropathy, as well as
cardiomyopathy, partial lipodystrophy, and mandibuloacral
dysplasia (Burke and Stewart, 2002). More recently, muta-
tions in lamin A have been linked to Hutchinson-Gilford
progeria syndrome in humans (De Sandre-Giovannoli et al.,
2003; Eriksson et al., 2003) and an analogous progeria-like
disease in a mouse model (Mounkes et al., 2003).
To extend our knowledge of the effects of CAAX process-
ing defects and to clarify the role of CAAX processing in the
organization of the nuclear lamina, we developed a mono-
clonal antibody that serves as a marker of CAAX endopro-
teolysis of lamin B1. We identify the lamin B1 CAAX en-
doprotease, show that lamin B1 is differentially “CAAX
processed” in interphase and mitotic cells, and demonstrate
the presence of a carboxymethylation-dependent lamin re-
ceptor in the nuclear envelope. Furthermore, we provide ev-
idence for the methylation–dependent organization of lamin
B1 into subdomains of the nuclear lamina, and describe
pathological changes in the nuclear envelope that result from
defective proteolytic processing of lamin B1.
 
Results
 
A monoclonal antibody specific for CAAX-processed 
lamin B1
 
A monoclonal antibody, 8D1, that reacted with the nu-
clear envelope of HeLa cells (Fig. 1 A) recognized lamin B1,
as determined by two-dimensional electrophoresis experi-
ments (Fig. 1 B). This antibody reacted differently with dif-
ferent isoforms of lamin B1 and failed to react with a bacte-
rially expressed His-tagged lamin B1 (Fig. 1 D), suggesting
that eukaryotic posttranslational modification is required
for the formation of the epitope. To determine whether the
region of lamin B1 recognized by the antibody was near to
the carboxyl-terminal CAAX motif, the last 13 or 25 resi-
dues of lamin B1 were fused to the carboxyl terminus of
lamin C. Antibody 8D1 reacted with the construct contain-
ing the last 13 residues of lamin B1 (Fig. 1
 
 
 
C). Expression
of His-tagged lamin B1 in HeLa cells in the presence of an
FTI (Fig. 1 D) prevented the acquisition of the epitope in
newly synthesized lamin B1 (although preexisting endoge-
nous protein in the nuclear lamina remained immunoreac-
tive, which is consistent with the slow turnover of the pro-
tein once inserted into the lamina; Moir et al., 2000).
Sequence alignment of the carboxyl-terminal 40 residues of
lamin B1, lamin B2, lamin C, and construct lamin C-C13
suggests that the specificity of the antibody is derived from
sequence differences immediately upstream of the CAAX
motif in lamin B1 and lamin B2, in addition to farnesyla-
tion of the cysteine residue (Fig. 1 E). To test whether fur-
ther CAAX modification in the form of carboxymethyl-
ation of the cysteine (after endoproteolysis) is required
for antibody reactivity, mouse embryonic fibroblasts from
wild-type and 
 
Icmt
 

 
/
 

 
 mice (Bergo et al., 2000) were sub-
jected to Western blot with 8D1 (Fig. 1 F). Antibody 8D1
reacted with lamin B1 from wild-type and knockout mouse
cell lines. The loss of the carboxymethylated isoform of
lamin B1 in the Icmt-deficient cells was confirmed by two-
dimensional electrophoresis and Western blot of total
lamin B1 (Fig. 1 G). The loss of the most neutral isoform
of lamin B1 is consistent with a lack of neutralization of the
carboxylate anion by a methyl group.
 
Rce1 is the lamin B1 CAAX endoprotease
 
To determine whether endoproteolysis of lamin B1 after far-
nesylation was required to create the epitope for antibody
8D1, mouse embryonic fibroblasts from wild-type embryos
and embryos deficient in the known CAAX endoproteases,
Rce1 and Zmpste24, were labeled with 8D1 and examined by
immunofluorescence microscopy and Western blot (Fig. 2, A
and B). 
 
Rce1
 

 
 and 
 
Zmpste24
 

 
 cells possessed endopro-
teolyzed, 8D1-positive lamin B1 at the nuclear periphery.
 
Zmpste24
 
 
 
cells were also positive, but 
 
Rce1
 

 
 
 
cells
failed to react with the antibody (also confirmed by Western
blotting; Fig. 2 C), suggesting that CAAX processing of lamin
B1 may be compromised in these cells. Optical sectioning by
confocal microscopy could not achieve the required resolution
in the Z-axis to obtain a mid-nuclear section in these fibro-
blast nuclei. Therefore, intranuclear signals of total lamin B1
and 8D1-positive lamin B1 may be, in part, the result of sig-
nals contributed from either basal or apical sections of the nu-
clear lamina. However, large intranuclear foci that readily la-
bel with the polyclonal antibody are not present in the 8D1
label; such foci have previously been reported in mouse fibro-
blasts (Moir et al., 1994). In addition, intranuclear invagina-
tions of the nuclear envelope (Fricker et al., 1997), which are
extensions of the peripheral nuclear membrane and lamina,
label with both the polyclonal antibody and 8D1.
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To confirm a defect of CAAX endoproteolysis of lamin
B1 in 
 
Rce1
 
 
 
cells, a heterologous reporter with the last
40 residues of lamin B1 containing the CAAX motif (con-
struct NLS-YFP-C40, which was small enough to discern
molecular mass differences due to endoproteolysis) was ex-
pressed in wild-type cells and cells deficient in Rce1 or
Zmpste24 (Fig. 2 D). The construct expressed in 
 
Rce1
 

 
cells migrated slower in SDS-PAGE compared with pro-
tein expressed in wild-type cells or cells deficient in either
Icmt or Zmpste24. The construct expressed in 
 
Icmt
 

 
cells runs as a doublet, suggesting partial endoproteolysis
in these cells. Two-dimensional electrophoresis of lamin
B1 from 
 
Rce1
 

 
 cells demonstrates a loss of the methyl-
ated isoform of lamin B1, which is consistent with an ab-
sence of carboxymethylation after CAAX endoproteolysis
(Fig. 2 E). 
 
Rce1
 

 
 cells still contain multiple isoforms of
lamin B1, three of which are common to the wild-type
control. Therefore, these charge differences are likely to
arise from modifications upstream of the CAAX motif of
lamin B1 and are consistent with the sequential addition of
negative charge, possibly in the form of phosphorylation
events. Importantly, the same isoforms that are labeled
with 8D1 in the wild-type cells do not label in the knock-
out line, suggesting that upstream modifications present in
these isoforms do not affect the ability of 8D1 to recognize
lamin B1. The posttranslational modifications recognized
by antibody 8D1 are summarized in Table I.
Figure 1. Monoclonal antibody 8D1 reacts with farnesylated 
lamin B1. (A) Immunofluorescence with 8D1 (green in merge) 
and the endoplasmic reticulum marker rhodamine–
concanavalin A (red in merge) show partial colocalization 
at the nuclear envelope of HeLa cells. (B) HeLa nuclear 
envelope proteins were separated by two-dimensional electro-
phoresis on 13-cm, pH 4–7, gradients and immunoblotted 
with 8D1 and commercial antilamin antibodies. 8D1 reactivity 
co-migrated with the reactivity of a commercial anti–lamin 
B1 antibody, but shows differential reactivity with isoforms 
of lamin B1, suggesting a posttranslational modification is 
required for formation of the epitope. No cross reactivity with 
lamin B2 is present. (C) Replicate Western blots with poly-
clonal anti-GFP and 8D1. YFP–lamin C (lane 1) was fused 
upstream of 13 (lane 2) or 25 (lane 3) residues of the carboxyl 
terminus of lamin B1 and expressed in HeLa cells. GFP–
lamin B1 is expressed as a control (lane 4). 8D1 reacted with 
lamin C fusion proteins containing the last 13 residues
of lamin B1 and, therefore, binds near the CAAX motif. (D) 
8D1 reacts with a eukaryotic posttranslational modification 
of lamin B1. Western blot with polyclonal anti–lamin B1 and 
8D1; (lane 1) His6-Xpress-lamin B1 expressed in bacteria; 
(lane 2) HeLa lysate; and (lane 3) His6-Xpress-lamin B1 
expressed in HeLa and (lane 4) in the presence of 100 M 
FTI III. Lower molecular mass band represents a carboxyl-
terminal apoptotic fragment of lamin B1. (E) Sequence align-
ment of the carboxyl terminal 40 residues of human lamin 
B1, lamin B2, construct lamin C-C13, human lamin C, and 
construct NLS-YFP-C13 (last 13 residues of lamin B1 fused 
directly to YFP). (F) Western blot of whole cell lysates from 
Icmt and Icmt mouse embryonic fibroblasts with 
8D1 and polyclonal anti–lamin B1 antibodies. 8D1 reacts 
with lamin B1 that is not methylated. (G) Two-dimensional 
electrophoresis on 13-cm, pH 4–7, gradients of total protein 
from Icmt (wild type) and Icmt (knockout) mouse 
embryonic fibroblasts followed by immunolabeling for total 
lamin B1 shows loss of the most neutral isoform of lamin B1 
in Icmt-deficient cells. Bars, 10 m.
 
Table I. 
 
Summary of reactivity of antibody 8D1 on lamin B1
CAAX modification
Carboxyl terminus
of lamin B1 8D1 reactive
 
Unmodified NRSCAIM No
Farnesylated NRSC(f)AIM No
Farnesylated and
endoproteolyzed
NRSC(f) Yes
Farnesylated,
endoproteolyzed and
carboxymethylated
NRSC(f)-ME Yes
A 15-carbon farnesyl moiety is covalently attached to the cysteine residue
to create a farnesyl cysteine (C(f)), followed by endoproteolysis (release of
AIM) and carboxymethylation (-ME).
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Proteolysis of lamin B1 requires 40 residues 
of upstream sequence
 
Various lengths of sequence upstream from the CAAX motif
of lamin B1 were fused to the carboxyl terminus of a re-
porter protein, NLS-YFP, that included a nuclear localiza-
tion sequence. Constructs included 13, 25, 40, 172, 200,
and 371 residues from the carboxyl terminus of lamin B1,
and were designed based upon the domain structure of the
protein (Fig. 3 A). These constructs were used in combina-
tion with antibody 8D1, a marker of CAAX endoproteolysis
of lamin B1, to study this processing event in HeLa cells.
Antibody 8D1 failed to recognize the fusion protein with 13
or 25 carboxyl-terminal residues (Fig. 3 B). The NLS-YFP-
C40 protein ran as a doublet on SDS-PAGE, indicating par-
tial carboxyl-terminal proteolysis in untreated cells but not
in FTI-treated cells, in which CAAX modification was pre-
vented. Moreover, antibody 8D1 reacted only with the
lower molecular mass, proteolyzed isoform (Fig. 3, C and
D). These results show that at least 40 residues of the car-
boxyl-terminal sequence of lamin B1 are required for en-
doproteolysis. Constructs with larger carboxyl-terminal re-
gions of lamin B1 all underwent endoproteolysis and all
were 8D1 immunoreactive. A polyglutamate tract is situated
 

 
30 residues upstream of the carboxyl terminus of lamin B1
and lamin B2 and may constitute a secondary recognition
motif for the endoprotease, in addition to the farnesyl-
CAAX motif.
 
Differential CAAX processing of lamin B1 
in interphase nuclei
 
Characterization of antibody 8D1 by Western blotting after
two-dimensional gel electrophoresis demonstrated differen-
tially processed pools of lamin B1 in free-cycling interphase
cells. Furthermore, we were able to differentiate the mature,
methylated isoform and the farnesylated, endoproteolyzed
but nonmethylated isoforms from unprocessed lamin B1 us-
ing a combination of two-dimensional electrophoresis and
immunolabeling with 8D1. The relationship between these
pools was examined by an analysis of nuclear protein frac-
tions from cells treated with cycloheximide or an FTI (Fig. 4
A). Western blotting with goat anti–lamin B1 polyclonal an-
tibody showed that the three major isoforms of lamin B1 are
reduced to two after inhibition of protein synthesis with cy-
cloheximide for 4 h. The intensity of the immunolabeling of
acidic isoforms was increased by treatment with an FTI, sug-
gesting that these isoforms represent a pool of nonfarnesy-
lated lamin B1. Labeling of the same blot membranes with
8D1 allows discrimination of the proteolyzed and methyl-
ated pools of lamin B1 from the nonproteolyzed forms. The
8D1-positive isoforms of lamin B1 in the immunoblots
represent methylated (fully processed, most neutral) and
endoproteolyzed, nonmethylated (more acidic) isoforms.
Thus, the depletion of the precursor pool by inhibiting ei-
ther protein synthesis or farnesyltransferase activity does not
result in the relentless progression toward the mature meth-
ylated pool (even over a 24-h period or one cell cycle in the
case of the FTI treatment). This suggests that interphase nu-
clei contain an independent pool of proteolyzed, but non-
methylated, lamin B1 and that progression to the mature
methylated form of lamin B1 may be regulated by other
posttranslational modifications (e.g., phosphorylation).
 
CAAX processing organizes domains within the 
nuclear envelope
 
The extent to which differentially “CAAX-modified” pools
of lamin B1 may reflect an organization within the nuclear
Figure 2. Rce1 is the lamin B1 CAAX endoprotease. Mouse 
embryonic fibroblasts from control mice and animals with homo-
zygous deficiency of either Rce1 (A) or Zmpste24 (B) were double 
labeled with goat anti–lamin B1 (green in merge) and 8D1 (red in 
merge). Images represent single confocal sections. Rce1-deficient 
cells do not label with 8D1. (C) Western blot of whole cell lysates 
from wild-type and Rce1- or Zmpste24-deficient mouse embryonic 
fibroblasts with 8D1 and polyclonal anti–lamin B1 antibodies 
confirms the lack of an 8D1 reactivity in Rce1 cells. (D) A 
heterologous reporter containing the last 40 residues of lamin B1 
including the CAAX motif, NLS-YFP-C40, was expressed in wild-
type and CAAX processing–deficient cells and analyzed by SDS-
PAGE and Western blot with an anti-GFP antibody. Primary anti-
body was detected with an alkaline phosphatase–conjugated 
secondary antibody and chromogenic substrate on the membrane. 
The protein migrates slower when expressed in Rce1 cells com-
pared with wild- type cells or cells deficient in Icmt or Zmpste24, 
indicating a defect in proteolysis. The doublet in Icmt cells is 
due to partial endoproteolysis. (E) Two-dimensional electrophoresis 
of total protein from wild-type and Rce1 deficient fibroblasts immuno-
labeled with polyclonal anti–lamin B1 and 8D1. Rce1 deficiency 
results in the loss of the methylated isoform of lamin B1. No isoforms 
of lamin B1 are reactive with 8D1 in Rce1 cells. Bars, 10 m.
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lamina and nucleoplasm was examined by confocal micros-
copy of HeLa cells that were labeled with both 8D1 and goat
anti–lamin B1 (Fig. 4 B). In untreated HeLa cells, both 8D1
and the polyclonal antibody show a characteristic distribu-
tion of lamin B1 in the peripheral nuclear lamina. A weak
punctate intranuclear distribution of lamin B1 (Moir et al.,
2000) was observed only with the polyclonal antibody and is
likely the nonfarnesylated precursor pool. After 24 h of FTI
treatment, the intranuclear nonfarnesylated pool was easily
visible; it diffusely filled the nucleoplasm and was excluded
from nucleoli. The peripheral lamin B1 signal detected by
the polyclonal antibody was unchanged compared with con-
trols, suggesting that lamin B1 may be directed to the nu-
Figure 3. The lamin B1 CAAX endoprotease requires 40 
residues of upstream sequence. (A) Schematic representation 
of full-length lamin B1 and carboxyl-terminal tail constructs. 
Increasing lengths of the lamin B1 carboxyl terminus were 
fused to the carboxyl terminus of NLS-YFP. (B) Constructs 
were expressed in HeLa cells in the absence and presence 
of 50 M FTI III and analyzed by Western blot with anti-GFP 
and 8D1. Constructs are indicated above lanes; the numbers 
represent the number of residues from the carboxyl terminus 
of full-length lamin B1. 8D1 reactivity is acquired when 40 
residues of lamin B1 sequence are present and is dependent 
on farnesylation. (C) Construct NLS-YFP-C40 is shown as an 
inset with 8D1 and anti-YFP signals aligned, indicating that 
8D1 recognizes a lower molecular weight band corresponding 
to proteolyzed lamin B1 carboxyl terminus. The data are de-
rived from a single nitrocellulose membrane that was reprobed 
to ensure perfect alignment of bands from the two antibodies. 
(D) The relative mobility of bands recognized by the antibodies 
is represented. 8D1 (solid line) recognizes endogenous lamin 
B1 and the reporter, which co-migrates with the shoulder 
present in the anti-YFP label (dotted line), corresponding to 
the lower molecular weight, endoproteolyzed species.
 
Figure 4.
 
Differential CAAX processing of lamin B1 in interphase 
cells.
 
 (A) Two-dimensional electrophoresis of proteins from purified 
HeLa nuclei and immunolabeling with goat anti–lamin B1 and 8D1 
antibodies demonstrates differential CAAX processing of lamin B1. 
Relative molecular mass and pI are shown. Nuclei purified from cells 
treated with cycloheximide (CHX) or farnesyltransferase inhibitor 
(FTI) demonstrate stability of two isoforms of lamin B1, representing 
methylated (arrow) and proteolyzed (arrowhead) isoforms. An acidic 
isoform of lamin B1 (asterisk), depleted by CHX treatment and in-
creased by FTI treatment, may represent a nonfarnesylated pool of 
lamin B1. (B) Single confocal sections of untreated and FTI-treated 
HeLa cells labeled with goat anti–lamin B1 (green in merge) and 
8D1 (red in merge) antibodies. FTI treatment increased the intranu-
clear pool of lamin B1 and decreased the mature pool of lamin B1 at 
the nuclear periphery even though total lamin B1 was maintained. 
The 8D1 signal was quantitatively lower in the nuclear lamina of 
FTI-treated cells and showed a discontinuous pattern. (C) FTI-treated 
cells were labeled with dilutions of polyclonal antibody to achieve 
similar signal intensities for both antibodies. Subdomains of CAAX-
processed lamin B1 identified by 8D1 are present in the lamina 
(shown at a higher magnification in the inset), compared with a more 
continuous pattern seen with the polyclonal antibody. Bars, 10 
 

 
m.
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clear periphery by alternative mechanisms, albeit less effi-
cient than farnesylation. Analysis of the 8D1 signal in FTI-
treated cells revealed a significant decrease in the amount of
mature lamin B1 despite the normal levels of total lamin B1.
Furthermore, the remaining 8D1-positive lamin B1 was not
uniformly distributed throughout the lamina but was con-
centrated in small domains not readily visible in untreated
cells. To ensure that this apparent organization of CAAX-
processed lamin B1 was not due to different intensities of
the label, FTI-treated HeLa cells were labeled with dilutions
of the polyclonal antibody to achieve a similar intensity to
the 8D1 label (Fig. 4 C). The same subdomains of the nu-
clear lamina could still be distinguished by 8D1.
 
Evidence for a carboxymethyl-lamin receptor 
in the nuclear envelope
 
Examination of the localization of NLS-YFP-C13 (Fig. 5
A) and NLS-YFP-C25 (not depicted) transiently expressed
in HeLa cells, showed that those proteins were localized
throughout the endomembrane system and plasma mem-
brane. In contrast, NLS-YFP-C40 localized to the nuclear
envelope of HeLa cells and was proteolyzed (Fig. 5 B). To
determine whether retention in the nuclear envelope re-
sulted from interactions with chromatin (e.g., interactions
between the polyglutamate tract and basic histone residues)
or was dependent on endoproteolysis and methylation,
NLS-YFP-C40 was expressed in wild-type and CAAX pro-
cessing–deficient cells (Fig. 5 C). NLS-YFP-C40 localized to
the nuclear envelope in each wild-type cell line and in
 
Zmpste24
 

 
 cells, but not in 
 
Rce1
 

 
 or 
 
Icmt
 

 
/
 

 
 cells.
Farnesylation was not affected in these cells as a reticular
pattern of NLS-YFP-C40, which colocalized with concana-
valin A, was seen in the cytoplasm, indicating association
with endomembranes (Fig. 5 D). In addition, expression of
the construct in the presence of an FTI resulted in a diffuse
nucleoplasmic accumulation (unpublished data). The intra-
nuclear levels of the reporter were greater in 
 
Icmt
 
-deficient
cells compared with 
 
Rce1
 
-deficient cells and may indicate
differences in the stability of membrane association resulting
from incomplete processing. These results indicate that car-
boxymethylation is a minimum requirement for the periph-
eral nuclear localization of the carboxyl-terminal tail of
lamin B1 fused to a heterologous reporter. Although full-
length lamin B1 localizes and is retained at the nuclear enve-
lope by integration in the nuclear lamina polymer through
homo- and possibly heterotypic interactions of the rod do-
main, in addition to binding to known inner nuclear mem-
brane proteins, our data suggest the presence of a carboxy-
methyl-lamin receptor at the nuclear envelope involved in
binding of the carboxyl-terminal end of the tail domain de-
pendent on the degree of posttranslational modification.
 
Defective CAAX processing results in morphological 
changes in the nuclear lamina
 
Because methylation of lamin B1 may be required for an in-
teraction with a component of the nuclear envelope, the ef-
fects of deficiencies in the CAAX processing of lamin B1 on
the nuclear lamina were examined by immunofluorescent la-
beling of mouse embryonic fibroblasts (Fig. 6 A). Defects in
proteolysis of lamin B1 (in 
 
Rce1
 

 
/
 

 
 cells) and carboxymeth-
ylation of all lamins (in 
 
Icmt
 

 
/
 

 
 cells) were associated with
an increase in morphological changes in the nuclear lamina
reminiscent of those caused by mutations in lamin A/C (Vi-
gouroux et al., 2001). Herniations of chromatin, evident by
Figure 5. A carboxymethyl-dependent lamin receptor in the nuclear 
envelope. (A) NLS-YFP-C13 (green in merge), representing the 
terminal 13 residues of lamin B1, was expressed in HeLa cells; the 
cells were fixed and labeled with 8D1 (red in merge). A single 
confocal section is shown. NLS-YFP-C13 localized throughout the 
endomembrane system and plasma membrane. The absence of 8D1 
reactivity confirms that the construct was not proteolyzed despite 
membrane association. (B) NLS-YFP-C40 (green in merge) expressed 
in HeLa cells localized to the nuclear envelope and was 8D1 positive 
(red in merge), confirming that CAAX processing took place. A single 
confocal section is shown. (C) Single confocal sections through the 
mid-nucleus of wild-type and knockout cell lines, deficient in 
individual CAAX-processing enzymes, expressing NLS-YFP-C40, 
show failure to localize to the nuclear envelope in Rce1 and 
Icmt cells. The nuclear envelope localization of NLS-YFP-C40 
was not affected in Zmpste24 cells. Intranuclear levels of the 
expressed protein were more pronounced in Icmtcells compared 
with Rce1 cells. (D) Farnesylation and membrane association 
was not impaired in Rce1- or Icmt-deficient cells. NLS-YFP-C40 is 
partially colocalized (merge) with rhodamine–concanavalin A in 
Icmt cells (not depicted) and Rce1 cells. Bars, 10 m.
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phase-contrast microscopy (Fig. 6 B), were less frequent in
control cells than in Rce1/ cells (1.3  0.6% vs. 4.1 
1.9%, P  0.07) or in Icmt/ cells (1.9  0.4% vs. 11.9 
3.2%, P  0.01). Defects in the nuclear lamina were also less
frequent in control cells than in Rce1/ cells (0.6  1.0%
vs. 12.4  4.2%, P  0.01) or Icmt cells (0.7  0.9%
vs. 9.1  3.9% for control and knockout, respectively, P 
0.02). Morphological changes were frequently localized to one
pole of the nucleus, which was consistent with previous stud-
ies (Sullivan et al., 1999; Vigouroux et al., 2001). Wild-type
cells and Zmpste24 cells were not significantly different
in herniations (5.9  2.0% vs. 5.0  2.5%, P  0.58) or in
lamina defects (5.5  3.0% vs. 5.5  1.9%, P  0.99).
The effects of farnesyltransferase inhibition on the lamina
were further demonstrated by quantitation of total and ma-
ture lamin B1 protein with 8D1 and goat anti–lamin B1 an-
tibodies on Western blots of cells treated with increasing
doses of an FTI (Fig. 6 C). Total lamin B1 was slightly up-
regulated, which accounts for the maintenance of lamin B1
in the peripheral lamina despite the increase in the intranu-
clear lamin B1 levels. The mature pool of lamin B1 decreased
to 60% of control levels after treatment with 25 M FTI III
(25% of the recommended dose). Thus, 8D1 could be useful
for monitoring the effects of FTI therapy (Adjei et al., 2000).
The effect of the decrease in mature lamin B1 on the nu-
clear lamina was measured by differential extraction of pro-
teins under increasingly stringent conditions (Fig. 6 D). FTI
treatment shifted the extraction profile of the total lamin B1
in the direction of the less stringent conditions compared
with control cells. This is due in part to the increased nucleo-
plasmic pool and in part to a compromise in nuclear lamina
integrity because the 8D1-positive mature lamin B1 in the
lamina also exhibits the shift toward release under less strin-
gent extraction conditions. The extraction data reveal the ef-
fect of FTI treatment and deficient CAAX modification on
the nuclear lamina; our data demonstrate the functional re-
lationship between differential CAAX processing of lamin
B1 and the organization of lamin B1 within the nucleoplasm
and nuclear lamina.
Two-step recruitment of lamin B1 
to postmitotic lamina
Examination of untreated mitotic HeLa cells by double label
immunofluorescence reveals a persistence of an 8D1-nega-
tive, nonproteolyzed pool of lamin B1 during mitosis and in
the subsequent recruitment of lamin B1 to the reforming
nuclear envelope (Fig. 7). The polyclonal antibody labels the
spindle region in the metaphase and anaphase cell, whereas
8D1 does not. In the telophase/early G1 cell shown, nuclear
envelope–associated lamin B1 was 8D1 positive, whereas cy-
toplasmic lamin B1 (which has yet to associate with the re-
forming envelope) was nonproteolyzed and 8D1 negative.
These data confirm that the differentially processed isoforms
of lamin B1, identified biochemically, correlate with the or-
ganization of lamin B1 in the nucleoplasm and nuclear lam-
ina in both interphase and mitosis.
Discussion
Our data support the identification of the lamin B1 endopro-
tease as Rce1, an enzyme with broad specificity for farnesy-
lated CAAX substrates. Rce1 substrates include Ras, G	 sub-
units, and a-factor in yeast (Kim et al., 1999; Otto et al.,
Figure 6. Defective CAAX processing of lamin B1 leads to morpho-
logical changes in the nuclear lamina. (A) Epifluorescence images 
of Rce1 and Icmt cells labeled with goat anti–lamin B1 
(green in merge) and DAPI (red in merge) for DNA. Defects in the 
lamina included abnormal distribution of lamin B1 in the periphery 
(arrows), often localized to one pole of the nucleus; peripheral lamina 
defects with no lamin B1 present (large arrowheads); and herniation 
of chromatin through peripheral defects (small arrowheads). (B) An 
epifluorescence image of an Icmt cell labeled with a polyclonal 
anti–lamin B1 antibody (green in merge) and DAPI (red in merge) 
shows a large herniation of chromatin (DAPI) and relative paucity 
of lamin staining overlying the herniation. The herniation is visible 
by phase-contrast microscopy of the same cell as an irregularity and 
protrusion of the nuclear envelope. (C) HeLa cells treated with 
doubling doses of an FTI were analyzed by Western blot with goat 
anti–lamin B1 and 8D1 antibodies. Over the period of a cell cycle, 
mature, 8D1-positive lamin B1 decreased to 60% of control levels. 
Total lamin B1 expression was up-regulated. Pre–lamin A accumu-
lated in a band of higher molecular weight. Lanes were loaded with 
equal amounts of total protein. (D) HeLa cells were treated with 50 
M farnesyltransferase inhibitor (FTI) III for 24 h or with 20 g/ml 
cycloheximide (CHX) for 4 h, or were untreated. Nuclei were puri-
fied and subjected to differential extraction. Samples were analyzed 
by Western blot with goat anti–lamin B1 and 8D1 antibodies and 
quantitated by densitometry. The amounts of total lamin B1 and 
mature (8D1 positive) lamin B1 in each extracted fraction are shown 
as a percentage of the total amount released. PNS, postnuclear 
supernatant. Bars, 10 m.
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1999; Dolence et al., 2000; Trueblood et al., 2000). Despite
this relatively broad specificity, the processing of lamin B1 re-
quires at least 40 residues of upstream sequence in addition to
the CAAX motif. The inability of Rce1 to process shorter car-
boxyl-terminal peptides of lamin B1 (13 or 25 residues)
stands in contrast with previous demonstrations of Rce1 activ-
ity on synthetic farnesylated tetrapeptides (Dolence et al.,
2000), on CAAX motifs fused to heterologous reporters, and
on short (9 residue) Ras sequences fused to reporters (Choy et
al., 1999). The previously held view that Rce1 requires a far-
nesylated CAAX motif as its only recognition motif does not
hold true for lamin B1 processing. Alternatively, the carboxyl
terminus of lamin B1 may include additional posttransla-
tional modifications that prevent endoproteolysis (e.g., phos-
phorylation) upstream of the CAAX motif.
Although Ras requires full CAAX processing (i.e., endopro-
teolysis and methylation) and a second upstream signal (in the
form of palmitoylation or a polybasic domain) to localize to
the plasma membrane (Hancock et al., 1991; Choy et al.,
1999), the carboxyl terminus of lamin B1 can direct a reporter
protein to the plasma membrane in the absence of endopro-
teolysis and methylation or any secondary targeting signals.
Association with endomembrane structures suggests that traf-
ficking through the Golgi complex is a likely route to the
plasma membrane, rather than direct association with the
plasma membrane itself (Choy et al., 1999).
The retention of the carboxyl terminus of lamin B1 in the
nuclear envelope was dependent on carboxymethylation, con-
firming that protein–protein interactions in the extreme car-
boxyl terminus are present and extending the notion of an iso-
prenyl-lamin receptor in the nuclear envelope to include
carboxymethylation. Because it has eight transmembrane do-
mains, the lamin B receptor has previously been proposed as an
isoprene receptor (Hennekes and Nigg, 1994). The degree to
which the farnesyl moiety interacts with the putative car-
boxymethyl-lamin receptor is not known, but will certainly in-
fluence identification of candidate inner membrane proteins
for this role. Because lamin A undergoes further proteolytic
processing upstream of the CAAX modifications (Kilic et al.,
1999), stable carboxymethyl-dependent interactions in the nu-
clear envelope are probably limited to B-type lamins. The acti-
vation of a cryptic splice site through a single base change in the
lamin A gene has recently been described in patients with
Hutchinson-Gilford progeria syndrome (Eriksson et al., 2003)
and results in a 50–amino acid deletion in the tail domain, in-
cluding the pre–lamin A protease site upstream of the CAAX
motif. Lamin A in these patients is expected to be constitutively
farnesylated and carboxymethylated; it is tempting to speculate
that this isoform of lamin A may compete with B-type lamin
interactions for binding to a carboxymethyl-lamin receptor.
The presence of a carboxymethyl-lamin receptor in the in-
ner nuclear membrane is made more significant by the find-
ing that lamin B1 exists in differentially carboxymethylated
states. Furthermore, the stability of these pools suggests ad-
ditional regulation of the progression toward the fully pro-
cessed methylated state. Coupled with the fact that the ma-
ture protein is shown to occupy subdomains of the nuclear
lamina, we propose that methylation of lamin B1 may be a
novel mechanism for higher-order organization of the nu-
clear lamina. Interactions with chromatin have been mapped
to the tail domain of lamin B1 immediately downstream of
the rod domain (Taniura et al., 1995; Stierle et al., 2003).
Although carboxymethylation may not influence lamin–
chromatin interactions themselves, methylation-dependent
binding of an inner membrane protein may organize periph-
eral chromatin interactions into domains along the lamina
polymer. Interphase phosphorylation of the lamina has been
proposed as a mechanism for generating heterogeneity in the
nuclear lamina independent of expression patterns of the
lamin proteins (Ottaviano and Gerace, 1985; Worman et
al., 1988). Carboxymethylation provides an additional, and
possibly dynamic (Chelsky et al., 1987), mechanism for reg-
ulation of domains within the lamina.
The nuclear lamina has been proposed as a structural compo-
nent in the binding of insulator elements responsible for
compartmentalization of chromatin domains (Labrador and
Corces, 2002). The boundary activity exhibited by components
of the yeast nuclear pore complex support the relationship be-
tween peripheral nuclear structure and function (Ishii et al.,
2002). Yeast cells do not contain lamin proteins. It is tempting
to speculate that the creation of subdomains in the nuclear lam-
ina by carboxymethylation of B-type lamins may provide a sim-
Figure 7. Two-step recruitment of lamin B1 at the 
end of mitosis. Single confocal sections of fluorescent 
labels and transmission images of mitotic HeLa cells 
double labeled with goat anti–lamin B1 (green in merge) 
and 8D1 (red in merge) antibodies demonstrate an 
unprocessed pool of lamin B1 throughout mitosis that 
localizes to the spindle region in metaphase and 
anaphase. In a telophase/early G1 cell, 8D1-positive 
mature lamin B1 is localized in the reforming envelope; 
a pool of 8D1-negative, nonproteolyzed lamin B1 was 
seen in the cytoplasm. Lamin B1 was recruited to the 
reforming nuclear envelope in two steps, dependent 
on the degree of carboxyl-terminal modification. 
Bars, 10 m.
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ilar mechanism for boundary activity or binding of insulator el-
ements in higher eukaryotes that express lamin proteins.
The nuclear lamina defects in cells deficient in Rce1 or
Icmt establish a potential mechanism for a novel laminopa-
thy involving a B-type lamin. The phenotypic changes seen
in these animal models (Kim et al., 1999; Bergo et al., 2001)
may be accounted for, at least in part, by lamina defects in-
troduced by aberrant processing of lamin B1. The pathoge-
netic mechanism of such a B-type laminopathy may depend
on the loss of interaction with a putative carboxymethyl-
lamin receptor in the nuclear envelope. Furthermore, FTIs
(Sebti and Hamilton, 2001) cause previously unidentified
changes in the expression and localization of lamin B1 (Dal-
ton et al., 1995), and potentially important consequences
for the integrity and organization of the nuclear lamina.
More recently, the longstanding cancer chemotherapeutic
agent, methotrexate, has been shown to exert its antiprolifer-
ative effect, at least in part through the inhibition of Icmt
(by increasing a metabolite intermediate that directly inhib-
its the enzyme) and, therefore, carboxylmethylation of pre-
nylated proteins (Winter-Vann et al., 2003). Because all of
the CAAX processing enzymes are potential chemotherapeu-
tic targets (Bergo et al., 2000, 2002a), an understanding of
the effects of inhibition on nuclear structure, gene expres-
sion, and peripheral chromatin silencing are essential in the
development of agents acting on these targets.
Materials and methods
Reagents 
Goat anti–lamin B1 antibody (model C20; Santa Cruz Biotechnology, Inc.)
was characterized by two-dimensional electrophoresis and confirmed to
be lamin B1 specific. Primary antibodies used included anti–lamin B1
(Chemicon), anti–lamin A/C (Novocastra), anti–lamin B2 (Novocastra), and
anti-GFP (CLONTECH Laboratories, Inc.). Anti–mouse, anti–goat, and
anti–rabbit secondary antibodies were obtained from Jackson ImmunoRe-
search Laboratories, conjugated to HRP or AP (for Western blot), or conju-
gated to Alexa 488 or Alexa 568 (Molecular Probes) for immunofluores-
cence microscopy. FTI III, a cell-permeable farnesyltransferase inhibitor,
was obtained from Calbiochem.
Lamin B1 constructs
Full-length lamin B1 cDNA was obtained from the IMAGE consortium
(clone 2969826; HGMP Resource Centre), amplified by PCR to introduce
restriction sites, and ligated into pTRC-His A (Invitrogen) with the BamHI
and XhoI sites to introduce a polyhistidine tag and an Xpress epitope tag at
the amino terminus. The coding region of the construct was amplified by
PCR with Pfu DNA polymerase (Promega) and introduced into pcDNA 3.1
(Invitrogen) for mammalian cell expression with the KpnI and XhoI sites.
GFP–lamin B1 was constructed by amplifying the EGFP sequence from
pEGFP-tubulin (CLONTECH Laboratories, Inc.) and introducing it up-
stream of the lamin B1 sequence in pcDNA 3.1 with KpnI and BamHI re-
striction sites. Tail domain constructs of lamin B1 were constructed by PCR
amplification and ligation downstream of NLS-YFP. Lamin C coding se-
quence (IMAGE clone 3355388; HGMP Resource Centre) was amplified
by PCR and introduced between NLS-YFP and lamin B1 carboxyl termini
C13 and C25. Lengths of lamin B1 carboxyl terminus used in these con-
structs included extreme carboxyl termini (C13 and C25); polyglutamate
tract (C40); carboxyl-terminal domain including the NLS (C172); entire
carboxyl-terminal domain including juxta-rod sequence (C200); and linker
2, coil 2, and rod domain together in C371. All constructs were sequenced
and confirmed to be free of mutations.
Cell culture and cell fractionation 
HeLa cells were grown in DME supplemented with 10% FCS and L-gluta-
mine (Invitrogen). Mouse embryonic fibroblasts were cultured as described
by Bergo et al. (2001). Cells were transfected with Lipofectamine 2000 (In-
vitrogen). Cells were treated with 20 g/ml cycloheximide for 4 h where in-
dicated to inhibit protein synthesis. FTI treatment was performed for 24 h in
all cases at a dose of 50 M FTI III, unless otherwise stated. Nuclei were pre-
pared at 4
C by Dounce homogenization in the absence of detergent as de-
scribed previously (Collas, 1998). A protease inhibitor cocktail containing 1
g/ml aprotinin, 1 mM phenylmethanesulphonyl fluoride, and 1 g/ml leu-
peptin was included during all steps of the isolation procedure.
Monoclonal antibody production 
Purified nuclei were digested with 20 g/ml DNase I and purified through
a sucrose cushion, and hydrophobic proteins were enriched by phase sep-
aration in Triton X-114 (Bordier, 1981). Balb/c mice were immunized, and
fusion of splenocytes to SP2 mouse myeloma cells and selection was per-
formed as described previously (Vaux and Gordon, 1985). Hybridomas
were screened by indirect immunofluorescence of HeLa cells as described
in Immunocytochemistry.
Extraction of purified nuclei 
and two-dimensional electrophoresis 
Aliquots of purified nuclei for two-dimensional electrophoresis were solubi-
lized immediately in isoelectric focusing sample buffer (9 M urea, 2% 3-[(3-
cholamidopropyl) dimethylammonio]-1-propanesulfonate, 20 mM DTT,
and 0.5% ampholyte). Isoelectric focusing was performed on an IPGphor
flatbed electrophoresis unit with 13-cm linear immobilized pH gradient
strips (pH 4–7; Amersham Pharmacia Biotech) for a total of 41,500 V-h (500
V for 1 h, 1,000 V for 1 h, and 8,000 V for 5 h). Equilibration for second di-
mension was performed in 6 M urea, 30% glycerol, 2% SDS, 50 mM Tris,
pH 6.8, with 60 mM DTT, followed by 135 mM iodoacetamide for 20 min
each. A 10% reducing SDS gel was used for the second dimension. For dif-
ferential extraction, purified nuclei from 5  107 cells were pelleted and re-
suspended in 300 l of nuclear isolation buffer (10 mM Hepes, pH 7.4, 2
mM MgCl2, 25 mM KCl, 250 mM sucrose, 1 mM DTT, and protease inhibi-
tors) and sonicated for two 5-s bursts at 10-m amplitude (Soniprep 150;
Sanyo). Insoluble material was pelleted in a microcentrifuge at 20,000 g for
5 min, and the supernatant was kept for analysis. The pellet was resus-
pended in 300 l of nuclear extraction buffer (1 M NaCl, 20 mM Hepes, pH
7.4, and protease inhibitor cocktail) and incubated at RT with agitation for
20 min (Otto et al., 2001). The procedure was repeated in nuclear extrac-
tion buffer with 2% Triton X-100, 4 M urea, and, finally, 8 M urea in se-
quential extractions. Samples were dialyzed against 1% SDS and 50 mM
Tris, pH 6.8, before gel electrophoresis. Bands were quantitated with IM-
AGEQuant software (Molecular Dynamics). Denaturing protein electro-
phoresis was performed with standard methods as described in Laemmli
(1970). Protein concentration was determined with a protein assay kit
(Bio-Rad Laboratories). Western blotting was performed in 5% milk in PBS
at optimal antibody concentrations. Where applicable, membranes were
stripped in 2% SDS and reprobed with a second primary antibody.
Immunocytochemistry 
Cells were grown on glass coverslips, washed in cold PBS, and fixed in 4%
PFA in PBS for 20 min at RT, permeabilized in 0.5% Triton X-100 in PBS
for 5 min, and blocked in 0.2% bovine gelatin in PBS. Antibody labeling at
optimum dilutions was performed for 45 min in a humidified chamber. La-
beled cells were mounted in Mowiol and counterstained with DAPI. Con-
focal microscopy was performed on a confocal laser-scanning microscope
(model MRC-1024 [Bio-Rad Laboratories]; model Lasersharp 2000 [Bio-
Rad Laboratories]). Epifluorescence microscopy was performed on an Ax-
ioplan II microscope (Carl Zeiss, Inc.) fitted with a Spot CCD camera (Di-
agnostic Instruments). Confocal images were viewed in Confocal Assistant,
and all images and figures were arranged in Adobe Photoshop.
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